Skip to content

Panchtikhta Panchprasritiki Vasti in Madhumeha ( Diabetes Mellitus Type 2)

Clinical Evaluation of effect of Panchtikta Panchprasritiki Vasti in Madhumeha ( Diabetes Mellitus Type 2) - Basti in DM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025211
Enrollment
40
Registered
2020-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: panchtikta panchprastriki basti: panchtikta panchprastriki basti in kala basti schdule in two coarse with gap period of 15 days after every coarse of kala basti. Control Intervention1:

Sponsors

Gurukul campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: newly diagnosed madhumeha (diabetes mellitus type 2) patient with hyperglycemia taking irregular medication, no medication, or mild medication.

Exclusion criteria

Exclusion criteria: patient having diabetes mellitus type 1 patient of diabetes mellitus type 2 on insulin patient with complication like renal failure, neuropathy, etc.

Design outcomes

Primary

MeasureTime frame
To assess the effect of therapy,objectively all sign and symptoms were given scoring depending upon their severity: 1- markedly improvement : 76-100% relief in sign and symptoms 2-moderate improvement: 51-75% relief in sign and symptoms 3-mild improvement:26-50% relef in sign and symptoms 4-no improvement: 0-25% relef in sign and symptoms.Timepoint: At 16th day, 32th day, 48th day,62th day

Secondary

MeasureTime frame
blood sugar fasting blood sugar pp hba1c urine examination routine urine examination microscopic hb% t.l.c, d.l.c, lipid profile lft kftTimepoint: At 16th day,32th day,48th day,62th day

Countries

India

Contacts

Public ContactDr Prof Uttam Kumar Sharma

Gurukul campus uau haridwar

druksm@rediffmail.com9411149479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026